Spotlight
Clinical
CME
Partners
Nidek's hyperopia algorithm tops FDA criteria
Fremont, CA-The FDA has given the go-ahead to an expansion of Nidek Inc.'s hyperopia study using new software for its U.S. EC-5000 platform.
Related Videos
Related Content
Fremont, CA-The FDA has given the go-ahead to an expansion of Nidek Inc.'s hyperopia study using new software for its U.S. EC-5000 platform.
